Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ischemic Heart Disease

  Free Subscription

Articles published in Curr Opin Cardiol

Retrieve available abstracts of 36 articles:
HTML format

Single Articles

    November 2020
  1. PAQUIN A, Poirier P, Beaudoin J, Piche ME, et al
    Secondary prevention after CABG: do new agents change the paradigm?
    Curr Opin Cardiol. 2020;35:664-672.
    PubMed     Abstract available

  2. WEISS AJ, Svensson LG, Bakaeen FG
    Temporal improvements in perioperative stroke rates following coronary artery bypass grafting.
    Curr Opin Cardiol. 2020;35:679-686.
    PubMed     Abstract available

  3. MADHAVAN MV, Stone GW
    Adverse events beyond 1 year after percutaneous coronary intervention.
    Curr Opin Cardiol. 2020;35:687-696.
    PubMed     Abstract available

  4. PU Z, Hakim D, Croce K, Stone PH, et al
    Preemptive percutaneous coronary intervention for coronary artery disease: identification of the appropriate high-risk lesion.
    Curr Opin Cardiol. 2020;35:712-719.
    PubMed     Abstract available

  5. SINHA A, Rahman H, Perera D
    Ischaemia without obstructive coronary artery disease: the pathophysiology of microvascular dysfunction.
    Curr Opin Cardiol. 2020;35:720-725.
    PubMed     Abstract available

  6. BUITEN RA, Zocca P, von Birgelen C
    Thin, very thin, or ultrathin-strut biodegradable or durable polymer-coated drug-eluting stents.
    Curr Opin Cardiol. 2020;35:705-711.
    PubMed     Abstract available

  7. MCKIERNAN M, Halkos ME
    Hybrid coronary revascularization: are we there yet?
    Curr Opin Cardiol. 2020;35:673-678.
    PubMed     Abstract available

    September 2020
  8. GUO MH, Nantsios A, Ruel M
    Appropriate therapy for patients with stable ischemic heart disease: a review of literature and the implication of the International Study of Comparative Effectiveness with Medical and Invasive Approaches trial.
    Curr Opin Cardiol. 2020 Sep 15. doi: 10.1097/HCO.0000000000000785.
    PubMed     Abstract available

  9. ELBATARNY M, Cheema AN, Mazine A, Verma S, et al
    Revascularization strategies for left main coronary artery disease: current perspectives.
    Curr Opin Cardiol. 2020;35:548-558.
    PubMed     Abstract available

  10. GE Y, Deva DP, Connelly KA, Yan AT, et al
    Stress cardiac MRI in stable coronary artery disease.
    Curr Opin Cardiol. 2020;35:566-573.
    PubMed     Abstract available

  11. WASSEF AWA, Liu S, Yanagawa B, Verma S, et al
    Percutaneous management of coronary bifurcation lesions: current perspective.
    Curr Opin Cardiol. 2020;35:574-582.
    PubMed     Abstract available

  12. KAPOOR K, Cainzos-Achirica M, Nasir K
    The evolving role of coronary artery calcium in preventive cardiology 30 years after the Agatston score.
    Curr Opin Cardiol. 2020;35:500-507.
    PubMed     Abstract available

  13. PRABHAKAR M, Liu S, Bagai A, Yanagawa B, et al
    Assessment and management of coronary artery disease in patients undergoing transcatheter aortic valve replacement.
    Curr Opin Cardiol. 2020;35:540-547.
    PubMed     Abstract available

  14. EIKELBOOM R, Muller Moran HR, Lodewyks C, Yan W, et al
    The COMPASS trial: practical considerations for application after coronary artery bypass surgery.
    Curr Opin Cardiol. 2020;35:583-588.
    PubMed     Abstract available

  15. EL-ANDARI R, Bozso SJ, Kang J, Nagendran J, et al
    A comparison of surgical, total percutaneous, and hybrid approaches to treatment of combined coronary artery and valvular heart disease.
    Curr Opin Cardiol. 2020;35:559-565.
    PubMed     Abstract available

    August 2020
    Mechanisms of myocardial infarction with nonobstructive coronary atherosclerosis: a multifaceted play of different actors with guarded prognosis.
    Curr Opin Cardiol. 2020 Aug 26. doi: 10.1097/HCO.0000000000000787.
    PubMed     Abstract available

    July 2020
  17. WU WY, Berman AN, Biery DW, Blankstein R, et al
    Recent trends in acute myocardial infarction among the young.
    Curr Opin Cardiol. 2020 Jul 16. doi: 10.1097/HCO.0000000000000781.
    PubMed     Abstract available

  18. WHITEHEAD E, Thayer K, Kapur NK
    Clinical trials of acute mechanical circulatory support in cardiogenic shock and high-risk percutaneous coronary intervention.
    Curr Opin Cardiol. 2020;35:332-340.
    PubMed     Abstract available

  19. GALOUGAHI KK, Petrossian G, Stone GW, Ali ZA, et al
    The year in review: advances in interventional cardiology in 2019.
    Curr Opin Cardiol. 2020;35:325-331.
    PubMed     Abstract available

  20. PARASKEVAS KI, Geroulakos G, Veith FJ, Mikhailidis DP, et al
    Multifocal arterial disease: clinical implications and management.
    Curr Opin Cardiol. 2020;35:412-416.
    PubMed     Abstract available

    March 2020
  21. FROST A, Haddad H, Shavadia J
    Mechanical circulatory support in cardiogenic shock.
    Curr Opin Cardiol. 2020;35:145-149.
    PubMed     Abstract available

    September 2019
  22. YANAGAWA B, Lee J, Puskas JD, Verma S, et al
    Revascularization in left ventricular dysfunction: an update.
    Curr Opin Cardiol. 2019;34:536-542.
    PubMed     Abstract available

  23. AL-SABEQ B, Nabi F, Shah DJ
    Assessment of myocardial viability by cardiac MRI.
    Curr Opin Cardiol. 2019;34:502-509.
    PubMed     Abstract available

  24. KHALAF S, Chamsi-Pasha M, Al-Mallah MH
    Assessment of myocardial viability by PET.
    Curr Opin Cardiol. 2019;34:466-472.
    PubMed     Abstract available

  25. PRADHAN J, Senior R
    Assessment of myocardial viability by myocardial contrast echocardiography: current perspectives.
    Curr Opin Cardiol. 2019;34:495-501.
    PubMed     Abstract available

  26. BERMAN AN, Blankstein R
    Current and future role of lipoprotein(a) in preventive cardiology.
    Curr Opin Cardiol. 2019;34:514-518.
    PubMed     Abstract available

  27. KHEMKA A, Sawada SG
    Dobutamine echocardiography for assessment of viability in the current era.
    Curr Opin Cardiol. 2019;34:484-489.
    PubMed     Abstract available

  28. BOCK A, Estep JD
    Myocardial viability: heart failure perspective.
    Curr Opin Cardiol. 2019;34:459-465.
    PubMed     Abstract available

  29. SPADACCIO C, Fremes SE, Gaudino MFL
    Right internal thoracic or radial artery as the second arterial conduit for coronary artery bypass surgery.
    Curr Opin Cardiol. 2019;34:564-570.
    PubMed     Abstract available

  30. MALHOTRA S, Gomez J, Doukky R
    Assessment of myocardial viability using single-photon emission computed tomography myocardial perfusion imaging.
    Curr Opin Cardiol. 2019;34:473-483.
    PubMed     Abstract available

  31. VERMA S, Sharma A, Kanumilli N, Butler J, et al
    Predictors of heart failure development in type 2 diabetes: a practical approach.
    Curr Opin Cardiol. 2019;34:578-583.
    PubMed     Abstract available

  32. RAJA SG
    Total arterial off-pump coronary revascularization: The Holy Grail?
    Curr Opin Cardiol. 2019;34:552-556.
    PubMed     Abstract available

    August 2019
  33. SILVAIN J, Kerneis M, Guerin M, Montalescot G, et al
    Modulation of cholesterol efflux capacity in patients with myocardial infarction.
    Curr Opin Cardiol. 2019 Aug 28. doi: 10.1097/HCO.0000000000000677.
    PubMed     Abstract available

    July 2019
  34. PATEL A, Marah N, Balan P
    Major trials in coronary intervention from 2018.
    Curr Opin Cardiol. 2019;34:323-328.
    PubMed     Abstract available

    June 2019
  35. LIU S, Tsang M, Abdel-Qadir H, Yanagawa B, et al
    Percutaneous coronary intervention for the management of stable ischemic heart disease.
    Curr Opin Cardiol. 2019 Jun 24. doi: 10.1097/HCO.0000000000000655.
    PubMed     Abstract available

    August 2018
    Physical activity and mortality in patients with stable coronary heart disease.
    Curr Opin Cardiol. 2018 Aug 22. doi: 10.1097/HCO.0000000000000563.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.